Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
308 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Saint Jude Medical Center
Fullerton, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
- Sharp Memorial Hospital
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Greenwich Hospital
Greenwich, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- Stamford Hospital/bennett Cancer Center
Stamford, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Christiana Gynecologic Oncology Llc
Newark, Delaware, United States
- Delaware Clinical and Laboratory Physicians Pa
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Medical Oncology Hematology Consultants Pa
Newark, Delaware, United States
- Regional Hematology and Oncology Pa
Newark, Delaware, United States
- Beebe Health Campus
Rehoboth Beach, Delaware, United States
- Nanticoke Memorial Hospital
Seaford, Delaware, United States
- Christiana Care Health System-Wilmington Hospital
Wilmington, Delaware, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Kootenai Medical Center
Coeur d'Alene, Idaho, United States
- Kootenai Cancer Center
Post Falls, Idaho, United States
- Kootenai Cancer Clinic
Sandpoint, Idaho, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Saint Joseph Medical Center
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Memorial Hospital of Carbondale
Carbondale, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Centralia Oncology Clinic
Centralia, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Cancer Care Center of Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Illinois Cancercare-Eureka
Eureka, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
- Western Illinois Cancer Treatment Center
Galesburg, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2012
- Primary completion
- 11 May 2016
- Completion
- 15 Apr 2017
- Last update posted
- 23 May 2018
- Registered enrollment
- 116
- Registry id
- NCT01648348
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.